CD1A
T-cell surface glycoprotein CD1a
Also known as: CD1, CD1A_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P06126
- Gene
- CD1A
- Ensembl
- ENSG00000158477
- Chromosome
- 1
- Canonical length
- 327 aa
- Protein class
- CD markers, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a member of the CD1 family of transmembrane glycoproteins, which are structurally related to the major histocompatibility complex (MHC) proteins and form heterodimers with beta-2-microglobulin. The CD1 proteins mediate the presentation of primarily lipid and glycolipid antigens of self or microbial origin to T cells. The human genome contains five CD1 family genes organized in a cluster on chromosome 1. The CD1 family members are thought to differ in their cellular localization and specificity for particular lipid ligands. The protein encoded by this gene localizes to the plasma membrane and to recycling vesicles of the early endocytic system. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]
Canonical amino-acid sequenceUniProt
327 residues, UniProt reviewed canonical sequence.
>P06126|CD1A
1 MLFLLLPLLA VLPGDGNADG LKEPLSFHVT WIASFYNHSW KQNLVSGWLS DLQTHTWDSN
61 SSTIVFLCPW SRGNFSNEEW KELETLFRIR TIRSFEGIRR YAHELQFEYP FEIQVTGGCE
121 LHSGKVSGSF LQLAYQGSDF VSFQNNSWLP YPVAGNMAKH FCKVLNQNQH ENDITHNLLS
181 DTCPRFILGL LDAGKAHLQR QVKPEAWLSH GPSPGPGHLQ LVCHVSGFYP KPVWVMWMRG
241 EQEQQGTQRG DILPSADGTW YLRATLEVAA GEAADLSCRV KHSSLEGQDI VLYWEHHSSV
301 GFIILAVIVP LLLLIGLALW FRKRCFCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CD1A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 296 nTPM
Expression across tissuesHPA
Tissue
- thymus: 296 nTPM
- skin: 26 nTPM
- esophagus: 9.7 nTPM
- tonsil: 3.6 nTPM
- lymph node: 2.6 nTPM
- appendix: 1.5 nTPM
Single-cell type
- cdc: 58 nCPM
- macrophages: 12 nCPM
- suprabasal keratinocytes: 2.2 nCPM
- monocytes: 1.7 nCPM
- platelets: 1.4 nCPM
- hofbauer cells: 1.1 nCPM
Immune cell
- myeloid DC: 11 nTPM
- memory B-cell: 10 nTPM
- classical monocyte: 6.4 nTPM
- naive B-cell: 5.3 nTPM
- intermediate monocyte: 4.2 nTPM
- total PBMC: 1.8 nTPM
Brain region
- hypothalamus: 0.1 nTPM
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- cerebral cortex: 0 nTPM
- choroid plexus: 0 nTPM
ReferencesPubMed · IEDB
Publications for CD1A from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
5 publications
- Brain immunohistopathological study in a patient with anti-NMDAR encephalitis.
2011 · Eur J Neurol · RCR 2.5 · 86 citations - Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice.
2000 · J Immunol · RCR 1.8 · 107 citations - The involvement of V(alpha)14 natural killer T cells in the pathogenesis of arthritis in murine models.
2005 · Arthritis Rheum · RCR 1 · 60 citations - Beta-galactosylceramide alters invariant natural killer T cell function and is effective treatment for lupus.
2009 · Clin Immunol · RCR 0.3 · 12 citations - Dermal dendritic cell number correlates with serum autoantibody titers in Brazilian pemphigus foliaceus patients.
2004 · Braz J Med Biol Res · RCR 0.2 · 10 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.95
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.61
- DepMap mean gene effect
- 0.12
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive immune response
- antigen processing and presentation, endogenous lipid antigen via MHC class Ib
- antigen processing and presentation, exogenous lipid antigen via MHC class Ib
- immune response
- positive regulation of T cell mediated cytotoxicity
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Immunoglobulin C1-set
- Immunoglobulin-like domain
- MHC class I-like antigen recognition-like
- MHC classes I/II-like antigen recognition protein
- Immunoglobulin-like fold
- Immunoglobulin-like domain superfamily
- MHC class I-like antigen recognition-like superfamily
- Antigen-presenting and immune regulatory MHC class I-related
- Immunoglobulin C1-set domain
- MHC-I family domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CD1A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CD1A as an antibody target. Whether an autoantibody or antibody against CD1A could matter depends on whether native CD1A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CD1A is annotated at the cell surface, where native CD1A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CD1A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...